DrugPatentWatch Database Preview
Details for Patent: 10,047,117
Try a free trial
See Plans and Pricing
Which drugs does patent 10,047,117 protect, and when does it expire?
Patent 10,047,117 protects OCALIVA and is included in one NDA.
This patent has fifty-eight patent family members in nineteen countries.
Summary for Patent: 10,047,117
| Title: | Preparation and uses of obeticholic acid |
| Abstract: | The present invention relates to obeticholic acid: ##STR00001## or a pharmaceutically acceptable salt, solvate or amino acid conjugate thereof. Obeticholic acid is useful for the treatment or prevention of a FXR mediated disease or condition, cardiovascular disease or cholestatic liver disease, and for reducing HDL cholesterol, for lowering triglycerides in a mammal, or for inhibition of fibrosis. The present invention also relates to processes for the synthesis of obeticholic acid. |
| Inventor(s): | Steiner; Andre (Raubling, DE), Waenerlund Poulsen; Heidi (Koge, DK), Jolibois; Emilie (Cambridge, GB), Rewolinski; Melissa (San Diego, CA), Gross; Ralf (Raubling, DE), Sharp; Emma (Cambridge, GB), Dubas-Fisher; Fiona (Cambridge, GB), Eberlin; Alex (Cambridge, GB) |
| Assignee: | Intercept Pharmaceuticals, Inc. (New York, NY) |
| Application Number: | 14/947,658 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; |
Drugs Protected by US Patent 10,047,117
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intercept Pharms Inc | OCALIVA | obeticholic acid | TABLET;ORAL | 207999-001 | May 27, 2016 | RX | Yes | No | Try a Free Trial | Try a Free Trial | TREATMENT OF PRIMARY BILIARY CHOLANGITIS (PBC) | Try a Free Trial | ||||
| Intercept Pharms Inc | OCALIVA | obeticholic acid | TABLET;ORAL | 207999-002 | May 27, 2016 | RX | Yes | Yes | Try a Free Trial | Try a Free Trial | TREATMENT OF PRIMARY BILIARY CHOLANGITIS (PBC) | Try a Free Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,047,117
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2013277429 | Try a Free Trial | |||
| Australia | 2016200832 | Try a Free Trial | |||
| Australia | 2016375566 | Try a Free Trial | |||
| Australia | 2017204057 | Try a Free Trial | |||
| Australia | 2018241172 | Try a Free Trial | |||
| Brazil | 112014031828 | Try a Free Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
